We build what we wished had existed.
The idea did not start with a market analysis. Type 1 is part of our own families, and the daily work around it was familiar to us long before there was a company. syncsulin was founded in 2025, a German technology startup and a small team in Düsseldorf. What we are working towards is a system that is intuitive, connected and honest about what it can do, so that type 1 takes up less of the day than it does now.
Meet the team
Alessandro Dani, PhD
Co-Founder
Alessandro holds a PhD in Chemistry and brings a deep passion for science to his role as the visionary founder of syncsulin. He is committed to applying a scientific approach to blood sugar regulation and strives to create a product that supports people with diabetes in making informed decisions about their health.
He brings over a decade of experience in both large companies and innovative start-ups, having held leadership roles including Chief Commercial Officer and Head of Business Development. Driven by creativity and a relentless pursuit of better solutions, he leads product development, research, and scientific validation, leveraging predictive AI to transform diabetes care and make advanced, intelligent diabetes management accessible to everyone.
Michael Munsch
Co-Founder
As Co-Founder of syncsulin, Michael is responsible for the company’s commercial and legal strategy as well as for building strong market and distribution partnerships. Driven by a passion for creating meaningful solutions, he combines a deep understanding of business strategy with a strong legal foundation - shaped by his studies at a leading business school and years of advising technology companies and start-ups.
Michael ensures that syncsulin’s innovations are developed on a solid and compliant foundation. His expertise spans commercial, IP, IT, and regulatory law, providing the framework that allows innovation to thrive safely and sustainably. Above all, his work is guided by the mission to make life with diabetes simpler, safer, and more predictable for millions of people.